These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28944519)

  • 1. A 15-year overview of increasing tramadol utilisation and associated mortality and the impact of tramadol classification in the United Kingdom.
    Chen TC; Chen LC; Knaggs RD
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):487-494. PubMed ID: 28944519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing tramadol utilisation under strict regulatory control of opioid prescribing - A cross-sectional study in Taiwan from 2002 through 2016.
    Chen TC; Wang TC; Lin CP; Bonar K; Ashcroft DM; Chan KA; Chen LC
    J Formos Med Assoc; 2021 Feb; 120(2):810-818. PubMed ID: 33011035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription opioid analgesics for pain management in Australia: 20 years of dispensing.
    Islam MM; McRae IS; Mazumdar S; Taplin S; McKetin R
    Intern Med J; 2016 Aug; 46(8):955-63. PubMed ID: 26602489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics.
    Karanges EA; Buckley NA; Brett J; Blanch B; Litchfield M; Degenhardt L; Pearson SA
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):504-512. PubMed ID: 29280224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tramadol for noncancer pain and the risk of hyponatremia.
    Fournier JP; Yin H; Nessim SJ; Montastruc JL; Azoulay L
    Am J Med; 2015 Apr; 128(4):418-25.e5. PubMed ID: 25460534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations.
    Ponizovsky AM; Marom E; Weizman A; Schwartzberg E
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):535-540. PubMed ID: 29488288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duplicated tramadol use in chronic low back pain: A nationwide cross-sectional study.
    Koo H; Lee MT; You SH; Seon JY; Lee S; Jeong KH; Jung SY
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):226-235. PubMed ID: 31520564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?
    Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):550-555. PubMed ID: 29047196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in opioid prescribing after federal rescheduling of hydrocodone products.
    Raji MA; Kuo YF; Adhikari D; Baillargeon J; Goodwin JS
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):513-519. PubMed ID: 29271049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing patterns of tramadol in adults in IMS® primary care databases in France and Germany between 1 January 2006 and 30 June 2016.
    Hedenmalm K; Slattery J; Skibicka-Stepien I; Kurz X; Morales D
    Eur J Clin Pharmacol; 2019 May; 75(5):707-716. PubMed ID: 30675632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons.
    Weisberg DF; Becker WC; Fiellin DA; Stannard C
    Int J Drug Policy; 2014 Nov; 25(6):1124-30. PubMed ID: 25190034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prescription drug monitoring programs in the United States of America].
    El Burai Félix S; Mack K
    Rev Panam Salud Publica; 2014 Oct; 36(4):270-6. PubMed ID: 25563153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany.
    Radbruch L; Glaeske G; Grond S; Münchberg F; Scherbaum N; Storz E; Tholen K; Zagermann-Muncke P; Zieglgänsberger W; Hoffmann-Menzel H; Greve H; Cremer-Schaeffer P
    Subst Abus; 2013; 34(3):313-20. PubMed ID: 23844964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study.
    Gallagher AM; Leighton-Scott J; van Staa TP
    Clin Ther; 2009 Aug; 31(8):1707-15. PubMed ID: 19808129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National trends in long-term use of prescription opioids.
    Mojtabai R
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):526-534. PubMed ID: 28879660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of seizures associated with tramadol.
    Jick H; Derby LE; Vasilakis C; Fife D
    Pharmacotherapy; 1998; 18(3):607-11. PubMed ID: 9620111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug experts call for stronger regulation of tramadol to reduce misuse.
    Mayor S
    BMJ; 2013 Feb; 346():f1264. PubMed ID: 23440344
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA confronts opioid addiction and overdose deaths.
    Furlow B
    Lancet Oncol; 2016 Mar; 17(3):e95. PubMed ID: 26877160
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serious adverse drug reactions with tramadol reported to the French pharmacovigilance database between 2011 and 2015].
    Moulis F; Rousseau V; Abadie D; Masmoudi K; Micallef J; Vigier C; Pierre S; Dautriche A; Montastruc F; Montastruc JL
    Therapie; 2017 Dec; 72(6):615-624. PubMed ID: 28755832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.